Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma

Lauren E. Haydu,Serigne Lo,Jennifer L. McQuade,Rodabe N. Amaria,Jennifer A. Wargo,Merrick I. Ross,Janice N. Cormier,Anthony Lucci,Jeffrey E. Lee,Sherise D. Ferguson,Robyn P. M. Saw,Andrew J. Spillane,Kerwin Shannon,Jonathan R. Stretch,Patrick Hwu,Sapna Pradyuman Patel,Adi Diab,Michael K. K. Wong,Isabella C. Glitza Oliva,Hussein Abdul-Hassan Tawbi,Matteo S. Carlino,Alexander M. Menzies,Georgina V. Long,Alexander J. Lazar,Michael T. Tetzlaff,Richard A. Scolyer,Jeffrey E. Gershenwald,John F. Thompson,Michael A. Davies

Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma

2020

PURPOSEImproved understanding of the incidence, risk factors, and timing of CNS metastasis is needed to inform surveillance strategies for patients with melanoma.PATIENTS AND METHODSClinical data w...

Keywords:

Cancer
CNS metastasis
Internal medicine
Medicine
Stage III melanoma
Oncology
Pathology
Cumulative incidence

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations